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Hypervolemia in Men from Drinking Hyperhydration Fluids at Rest and During
Exercise
J. E. GREENLEAF, R. LOOFF-WILSON, J. L. W1SHERD, P. P. FUNG, A. C. ERTL, C. G. R. JACKSON, P. R. BARNES,
AND L. G. WONG*
Ames Research Center
Summary
To test the hypothesis that drink composition is more
important than drink osmolality (Osm) for maintaining
and increasing plasma volume (PV) at rest and during
exercise, six men (22-39 yr, 76.84 + 16.19 kg,
2.99 + 0.45 L/rain VO 2 peak) each underwent six treat-
ments while sitting for 90 rain ( VO 2 = 0.39 L/rain) and
then performed upright ergometer exerc!se for 70 rain
(_'O 2 = 2.08 + 0.33 l/rain, 70% + 7%__VO2 peak). Drink
formulations (10 ml/kg body weight, X = 768 ml) for the
sitting period were: P1 (55 mEq Na +, 365 mOsm/kg
H20), P2 (97.1 mEq Na +, 791 mOsm/kg), P2G (113 mEq
Na +, 80 ml glycerol, 1,382 mOsm/kg), HyperAde (HA)
(I64 mEq Na +, 253 mOsm/kg), and 01 and 02 (no drink-
ing). The exercise drink (10 ml/kg, 768 ml) was PI for all
treatments except 02. Plasma volume at rest increased
(p < 0.05) by 4.7% with PI and by 7.9% with HA. Percent
change in PV during exercise was +1% to +3% (NS) with
HA; -6% to 0% (NS) with P1, P2, P2G, and 01; and -8%
to -5% (p < 0.05) with 02. HyperAde, with the lowest
osmolality (253 mOsm/kg), maintained PV at rest and
during exercise, whereas the other drinks with lower Na +
and higher osmolality (365 to 1,382 mOsm/kg) did not.
But Performance 1 also increased PV at rest. Thus, drink
composition may be more important than drink osmolality
for increasing plasma volume at rest and for maintaining
it during exercise.
Introduction
The mechanism of muscular fatigue caused by physical
work and exercise (high metabolism) is not clear, but it
involves disturbance of muscle surface membrane
excitation-contraction coupling as a result of changes in
sarcoplasmic reticulum Ca 2+ release, cell H + and inor-
ganic P responses, and carbohydrate metabolism (Fitts
1994). Low-metabolism fatigue in people at rest involves
both psychological and physiological factors (Bartlett
1953, Booth 1991), probably in various proportions. One
common factor appears to be the concentration and distri-
*Shaklee U.S., Inc., San Francisco, California.
bution of water and electrolytes within muscle cells and
other body fluid compartments (vascular, interstitial, and
cellular). The vascular fluid volume, composed of plasma
and red blood cells, is a primary regulator of cardiovascu-
lar function; reduction of this volume (hypovolemia) and
total body water (hypohydration) adversely affects exer-
cise performance (Greenleaf 1973). In addition, plasma
volume and ionic-osmotic constituent concentration of
plasma and cells are also regulatory factors for body
thermoregulation, which is often compromised with
exercise-induced hypovolemia and hypohydration
(Greenleaf and Castle 1971, Greenleaf 1979, Kozlowski
et al. 1980).
Rehydration of dehydrated people is relatively easy with
appropriate food (osmols), fluid, and a restful environ-
ment. But ad libitum fluid intake under stressful condi-
tions, e.g., heat, exercise, or prior dehydration, results in
involuntary dehydration (Greenleaf 1991, 1992; Rothstein
et al. 1947) defined as the delay in full fluid replacement
(euhydration) during and following loss of body fluid.
Stress caused by doing mental arithmetic can also cause
hypovolemia (S. Patterson, personal communication).
Thus, people subjected to acute or chronic stress may be
somewhat "dehydrated" as well as fatigued.
Research on body fluid distribution and rehydration fluid
composition, stimulated by demands on troops during
World War II (Adolph 1947, Pitts et al. 1944), has contin-
ued with increasing intensity for military personnel
(Marriott 1994) with application for recreational exercis-
ers and competitive athletes (Murray 1987). Many current
rehydration formulations are more concentrated
(hypertonic-hyperosmotic) than the normal plasma osmo-
lality (285 mOsm/kg H20) with more of the drink osmols
contributed by carbohydrate than by ionized solute
(Murray 1987). Optimal fluid composition for rapid gas-
tric emptying and transfer through the gastrointestinal
system appears to be 20-30 mEq/L sodium, 5-10 mEq/L
potassium (with chloride as the only anion), and
0.9%-10% carbohydrate, preferably glucose (Gisolfi
1991). Measurement of gastric and gastrointestinal
empty ing of fluid does not necessarily reflect change in
plasma or interstitial fluid volumes. There have been few
studiesontheefficacyof variousdrinkformulationsfor
increasingbodyfluidcompartmentvolumes,especially
plasmavolume(PV)inrestedhydratedsubjects(LuetkemeierandThomas1994;MaughanandNoakes
1991,Murray1987).
Recentfindingsinourlaboratoryindicatedthatfluidfor-
mulationscontaininggreaterconcentrationfionized
solute(Performance1andHyperAde)upto164mEq/L
Na+inducesignificantly(p<0.05)greaterlevelsof
hypervolemiainresting,moderatelydehydratedmen,and
arealsobetterthanwaterforattenuatingthehypovolemia
duringsupine,submaximal,legergometerxercise
(Greenleafetal.1992).Thepresentstudywasdesigned
fromthesepreliminaryfindingstodeterminetheeffectof
intermittentingestionoftwopreviouslytestedandtwo
newlyformulatedhypertonicsolutionscontainingvarious
osmoticandcarbohydrateconcentrationsonplasmavol-
umeduringrestfollowedbyuprightsubmaximalergome-
terexercise.Totesthephysiologicaleffectofthe
hyperhydration,thermoregulatoryparameterswere
measured.
Theauthorsthankthesubjectsfortheirdedicationand
cooperation.ThisstudywassupportedbyShakleeGrant
JSRA-7andNASAGrants199-18-I2-07andNAG8-227.
Methods
Subjects
Six men, aged 22-39 yr, (table 1) gave written informed
consent for this study which was approved by the Ames
Research Center Human Research Experiments Review
Board and the San Francisco State University Human
Subjects' Committee. The men passed a comprehensive
medical examination which included their medical his-
tory, urine and blood analyses, and a treadmill exercise
test. All were nonsmokers and none took nonprescribed
drugs.
Procedure
Six treatments for each subject were conducted semi-ran-
domly at weekly intervals. The experimental protocol
consisted of intermittent drinking during 90 rain of sitting
rest, 15 min to move to the cycle ergometer and to read-
just sensors, intermittent drinking during 70 min of
upright submaximal (70% + SD 7% of peak oxygen
uptake) leg exercise, followed by 10 min of sitting recov-
cry (fig. 1).
The subjects arrived at the Laboratory for Human Envi-
ronmental Physiology at 0700 hr and ate a standardized
carbohydrate breakfast: 220 ml of reconstituted frozen
orange juice and two toasted English muffins with jelly.
After breakfast they urinated and inserted a rectal thermis-
tor 16 cm. Dressed in shorts (weighed dry), they were
weighed (+_5g) on a digital scale (model 5780, National
Controls, Inc., San Carlos, California). The men then sat
in a chair for 90 min while skin probes and sensors (EKG,
laser-Doppler, temperature, and sweat capsules) were
attached and a forearm venous catheter (Quik-Cath,
Travenol Laboratories, Inc., Deerfield, Illinois) was
inserted. Body weight was measured and additional urine
samples were collected after the rest and exercise periods
(fig. 1).
Drinks and Drinking
Each subject drank one of four fluid formulations
(table 2), divided into seven portions, during the rest and
exercise periods (fig. 1). The drinks were designated P1
(Performance 1), P2 (2 x Performance 1 concentration),
P2G (P2 + 80 ml glycerol), HA (HyperAde), or 0 (no
drinking). Performance 1 is a commercial product of
Shaklee U.S., Inc., San Francisco, California; HyperAde
was also packaged by Shaklee. All drinks, in powder
form, were mixed just prior to testing. The high salt con-
tent of HA, as well as the very sweet taste of P2G, were
apparent to the subjects. Drink volume was 10 ml/kg body
weight for both resting and exercise phases (table 3).
Glycerol was used for its water retaining properties. Per-
formance I was consumed during exercise with five
treatments, and no drinking was done during the sixth.
Thus, for the six treatments, drink designations for
rest/exercise, respectively, were: PI/P1, P2/P1, P2G/P1,
HA/P l, O/P I, and 0/0.
Physiological Measurements
After three familiarization sessions, the peak oxygen
uptake (VO 2 peak, table 1) was measured with the sub-
jects in the upright sitting position on a model 846 cycle
ergometer (Quinton Instruments Co., Seattle, Washing-
ton). The respiratory measurement system utilized a low-
resistance, low-dead-space Rudolph Valve (model 2700,
Hans Rudolph, Inc., Kansas City, Missouri), a Tissot-tank
calibrated electronic spirometer (model S-301 Pneu-
moscan, K.L. Engineering Co., Sylmar, California), and a
3-L mixing chamber from which expired gas was sampled
at 0.5 L/min, drawn through and dried by anhydrous
calcium sulfate (N.A. Hammond Drierite Co., Xenia,
Ohio) and routed to oxygen and carbon dioxide analyzers
(Applied Electrochemistry models S-3AI and CD-3A,
respectively; Ametek, Thermox Instruments Division,
Pittsburg, Pennsylvania). The analyzers were calibrated
with standardized gases (Lloyd-Haldane apparatus).
Analogdatawereprocessedon-linewithananalog-to-
digitalconverter(VISTAsystemIBMmodel17002,
Vacumed,Ventura,California)andtransmittedtoanIBM
(modelAT)computer;outputmetabolicdatawereprinted
each15sec.Peakdatawerethemeanofthefinalfour
15-secvalues.Thesubmaximalexerciseloadcorre-
spondedtoanoxygenuptakeof 70%+ SD 7% of the
measured VO 2 peak (table 4).
Skin blood velocity was measured on the left temple and
left anterior-medial thigh with a laser-Doppler system
(model BPM 403A, LaserFlo Blood Perfusion Monitor,
TSI Inc., St. Paul, Minnesota). Heart rate was determined
with a cardiotachometer (model 78203C, Hewlett-
Packard, Waltham, Massachusetts) via three skin elec-
trodes (Silvon No. 01-3630 Ag/AgCI, NDM, Dayton,
Ohio), two located on the anterior shoulders and the third
over the fifth intercostal space.
Local sweat rate was measured via capsules (Spaul 1983)
on the left arm, forearm, and anterior thigh with resistance
hygrometry sensors (model 2300 HIT21, Thunder Scien-
tific Corp., Albuquerque, New Mexico); room air was the
reference. The sweat capsules were located adjacent to
skin-temperature thermistors. The sensors were calibrated
with solutions of standard humidity: 33% with MgC12,
52% with MgNO3, and 96.5% with K2SO4, and room air
(43.5%) was measured with a psychrometer. Regression
equations for measured versus actual humidities were:
thigh (Y = I. 10 X - 0.78, r = 0.99), forearm (Y = 1.03
X-4.97, r = 0.98), and arm (Y = 1.15 X =-i3.40,
r = 0.99). Sensor and room air relative humidities were
recorded with a DigiTech Datalogger (model 1100,
United Systems Corp., Dayton, Ohio). Sweat rate ( Msw )
at.the three sites was calculated as follows: iVlsw =
[ V a(Wout - Win)]/[(Asw)(SVA)] where /Vlsw = sweat
rate (g. cm -2. hr-1), Va = volume flow rate (L/min),
Wout, = absolute humidity ratio leaving capsule
(Ib H20/Ib dry air), Win = absolute humidity ratio of
control (ib H20/Ib dry air), Asw = area of collection
capsule (3.14 cm2), and SVA = specific volume of air
(L/g dry air).
Body water balance (gross sweat rate) was calculated:
balance = (weight loss - blood + urine loss + drink
volume) - (CO2 out - 02 in).
Rectal and skin temperatures were measured with series
400 thermistors (Yellow Springs Instrument Co., Yellow
Springs, Ohio). Skin thermistors, attached with holders
that permitted free movement of air (Greenleaf and
Williams 1976), were located at six sites: arm, forearm,
thigh, calf, chest, and back. A Squirrel meter/logger
(Grant model 1200, Science/Electronics Inc., Miamisburg,
Ohio) was used for processing sensor signals. Mean skin
temperature ( Tsk ) (Greenleaf and Castle 1972, Hardy
and Dubois 1938) was calculated: Tsk = 0.06 (Tarm)
+0.13 (Tforearm) +0.21 (Tthigh) +0.21 (Tcalf) +0.19
(Tchest) +0.20 (Tback). Mean room dry-bulb temperature
was 21.8°C + SD 0.3°C, and relative humidity was
50% + 2% (table 5). A fan increased airflow over the
subject during rest (23 + SD 4 ft/min) and exercise
(53 + 4 ft/min).
Blood Measurements
Blood samples (15 ml each (20 ml each at -25 and
-35 min), 115 ml/experiment) were withdrawn through an
! 8-gauge catheter (Quik-Cath, Baxter Healthcare Corp.,
Deerfield, Illinois) inserted into the right antecubital vein.
Blood samples were divided in four Vacutainer R tubes:
tube 1 = 2 ml for hemoglobin (Hb) and hematocrit (Hct);
tube 2 = 3 m! for glucose; tube 3 = 10 ml for sodium,
potassium, osmolality, RBC, WBC, platelets, and glyc-
erol; and tube 4 = 5 ml for Evans blue (plasma volume)
analysis. Hemoglobin and Hct were measured immedi-
ately (manually). Hemoglobin was measured (cyano-
methemoglobin method) with the Coulter Diluter II and
Hemoglobinometer (Coulter Electronics, Hialeah,
Florida). Blood for Hct was drawn into four capillary
tubes, centrifuged for 10 min at 11,500 rpm (centrifuge
model MB, International Equipment Co., Needham
Heights, Massachusetts) and read with a modified micro-
capillary tube reader (model CR, International Equipment
Co.). Hemoglobin and Hct were also calculated automati-
cally with a Coulter model STKS analyzer. Plasma was
frozen (-20°C) for subsequent analysis.
Plasma sodium, potassium, glucose, citrate, and glycerol
concentrations were measured with a Cobas Mira S
analyzer (Roche Diagnostic Systems, Inc., Branchburg,
New Jersey): sodium (glass membrane) and potassium
(PVC valinomycin membrane) with ion-selective
electrodes; glucose with hexokinase-NAD reactions and
NADH read at 340 nm; glycerol with glycerolkinase-
glycerophosphate oxidase-peroxidase reactions with the
quinoneimine complex read at 490-550 nm; and citrate
with citrate lyase for NADH to NAD ÷ at 340 nm. Plasma
osmolality was measured by freezing-point depression
(model 3DII, Advanced Instruments Digimatic Osmome-
ter, Needham Heights, Massachusetts).
Plasma volume was measured on frozen plasma with the
Evans blue dye (T-1824, New World Trading Corp.,
DeBary, Florida) dilution technique from one 10-min
post-dye-injection blood sample (Campbell et al. 1958,
Greenleaf et al. 1979). Freezing does not change T-1824
concentration over time. Plasma was eluted through
machine-packed chromatographic columns (model PD-I0,
Sephadex G-25M, Pharmacia LKB, Uppsala, Sweden)
and the elutriate was read at 615 mB. Plasma volume was
calculated:PV=(V • D- St.v)/(T•1.03)where
V = volumeT-1824injected,D=dilutionofstandard,
St= standardabsorbanee,v= volumeofsamplextracted,
T=testsampleabsorbance(subtractplasmablank),and
1.03= correctionfactorforslowdyeuptakebytissues.
Percentchangeinplasmavolumewascalculatedusingthe
Hb-Hctransformationequation(Greenleafetal.1979).
DatafromthenewSephadexcolumnwerecomparedwith
datafromthestandardmanuallypackedcolumn
(Greenleaf1979b).Theopticaldensityof0.2ml
T-1824/10mlacetonestandardwasmeasured(0.130);
then0.2mlT-1824wasmixedwithTeepol-phosphateand
elutedthroughninemanuallypackedchromatographic
columnsandnineSephadexcolumns.Mean(+SDand
+SE) optical density for the manual and Sephadex
columns was 0.1103 (+0.0041 and _-_+0.0014)and 0.0949
(_+0.0026 and _+0.0008), respectively (A X = 14.0%,
p < 0.0001). Thus, optical density from the Sephadex col-
umn was lower and variability of the elutriate was about
half that of the manually packed column.
Mean corpuscular volume (MCV, I.t3) = 10 (Hct. 0.96)/
(RBC in 106/mm3).
Hematocrit and hemoglobin concentration were deter-
mined manually (as indicated above) and with calculated
values from the Coulter counter (fig. 2). The calculated
Hb values were lower and the Hct values were higher than
their respective manual values which were used for the
plasma and blood volume determinations.
Urine Measurements
The volume of urine, collected at the end of rest (-15 min)
and after exercise (+10 min of recovery), was timed and
measured in a graduated cylinder. Urinary excretion rate
(V) was expressed in mL/min. Urinary sodium (UNa),
potassium (UK), and osmotic (Uosm) concentrations were
determined by the same methods used for the respective
plasma variables. Other urine functions were calculated:
osmotic clearance (Cosm) was urine osmotic excretion
(Uos m "(/) divided by plasma osmolality (Posm) averaged
over the urine collection period; free water clearance
(CH2Q) was '_/- Cosm; and fractional ionic excretion was
UNa V andUKV.
Statistical Analysis
The data were analyzed, as a first approximation, by Stu-
dent's t-test for dependent variables. The null hypothesis
was rejected when p < 0.05. Nonsignificant differences
were denoted by NS or trend or tendency,
Results and Discussion
Blood Data
Plasma and mean corpuscular volume- Percent change
in plasma volume from -105 min (upper panel), and from
-105 rain (rest) and from 0 rain (exercise) (lower panel),
are presented in figure 3. At the end of the rest phase
(-15 min) the greater (p < 0.05) increase in PV occurred
with the HAPI (by 7.9%) and P1PI (by 4.7%) treatments;
the lesser increase was with the 00 (by 1.7%) and 0P1 (by
1.0%) treatments. Change from sitting upright in a chair
with the thighs horizontal, to sitting upright on the cycle
with thighs positioned at a more downward angle
(position change) resulted in decreasing trends in PV at
time zero with all treatments which resulted from the
increased hydrostatic pressure in the lower extremities.
Percent change in PV with 0P1 at time zero was similar to
that of 00, so the two no-drinking treatments responded
similarly. During exercise, HAPI maintained the highest
PV, followed by PIP1,0P1, P2GP1, P2P1, and 00 in
decreasing order (fig. 3, upper panel). Thus, drinking P1
during exercise by dehydrated subjects can increase PV to
the hydrated-control level. Reduction in PV by 4% to 9%
occurred with all treatments at 10 min of exercise, with
essentially similar rates of recovery regardless of whether
or not fluid was consumed (fig. 3, lower panel). The 00
response was similar to the P2GP1 response. Thus, the
rate of PV restitution during exercise appeared to be inde-
pendent not only of drink composition, but also of
whether or not fluid was consumed.
Mean corpuscular volumes (fig. 4) were not different
from each other or over time during rest or exercise, indi-
caring that there was no appreciable exchange of vascular
fluid into or from red blood cells.
Osmolality- Plasma osmotic concentration was within
the upper half of the normal range (277-297 mOsm/kg
H20) and varied between 288 and 293 mOsm/kg H20 in
the rest phase (fig. 5, upper panel). In both nondrinking
treatments (0P1 and 00), plasma osmolality remained
constant during the first hour of rest. Osmolality varied by
+2 mOsm/kg by the end of rest; P1PI and P2GPI exhib-
ited positive changes and HAP2 and 0P1 exhibited nega-
tive changes (fig. 5, middle panel). All osmotic responses
were within the normal variability. Plasma osmolality
increased during exercise with all treatments, especially
0PI (with drinking PI) and 00 (with no drinking). Intake
of PI had no apparent effect on change in osmolality.
Drinks P2GPI and HAP1 had the lower osmotic concen-
tration at the end of exercise (fig. 5, upper panel) which
accompanied the greater increase in plasma volume. As
expected, treatment 00 exhibited the greatest increase in
osmolalitybytheendofexercise;HAPIhadtheleast
increase(fig.5,middlepanel).Also,HAPI,withthe
highestionicosmolality,hadthegreatestincreasein
plasmaosmoticontent;osmoticontentoftheremaining
treatmentsreturnedtonormalbytheendofexercise
(fig.5,lowerpanel).Theacutedecreaseinplasma
osmoticontentatthebeginningofexerciseaccompanied,
andpossiblyinduced,theshiftofplasmafromthevascu-
larspace.
Sodium-Plasmasodium concentration generally fol-
lowed comparable osmotic concentration, especially when
respective percent change in content was compared
(figs. 5 and 6, lower panels). Because sodium and accom-
panying anions account for a large part of plasma osmo-
lality (plasma sodium and osmotic concentrations
r = 0.93), the osmotic contribution of carbohydrates was
minimal.
Potassium- Plasma potassium was within the normal
range at rest (fig. 7, upper panel) and, unlike sodium, both
potassium concentration and content exhibited immediate
increase with the onset of exercise (fig. 7, lower panel).
The potassium content in the drinks did not appear to
influence the concentration or content responses at rest or
during exercise. At 70 min of exercise the greater percent
change in content occurred in HAPI, 0P1, and P2PI
(containing potassium), and the smallest change occurred
in P1P1 (also containing potassium), with 00 (containing
no potassium) in the middle (fig. 7, lower panel). Thus
potassium, the major intracellular ion, did not accompany
the shift of sodium and water from the vascular space at
the beginning of exercise.
Glucose- Plasma glucose was elevated above the normal
range of 64-115 mg/dL at the beginning of the rest
period, probably a result of the high-carbohydrate break-
fast (fig. 8, upper panel). Glucose concentration decreased
with all treatments during rest and position change, with a
greater decrease for those with no carbohydrate (HAP1,
00, 0P1). With the exception of HAPI, glucose concentra-
tion and content decreased immediately with the onset of
exercise (similar to osmolality and sodium), and then
increased as exercise continued (fig. 8, lower panel). Glu-
cose concentration for treatments 0P1 and 00 were similar
at time zero, but by the end of exercise that of 0Pi
increased the most (to 110 mg/dL) and that of 00
increased the least (to 85 mg/dL) by 70 rain (fig. 8, upper
panel). Similar results were evident with changes in glu-
cose concentration and content. Thus, consumption of
glucose during exercise increased both plasma glucose
concentration and content.
Glycerol- Only one drink (P2G) contained appreciable
(80 mL) glycerol. Plasma glycerol increased to
168 + 33 mg/dL at zero min of rest, remained at that level
during the first 30 rain of exercise, and then decreased to
116 ___18 mg/dL at 70 rain (fig. 9, upper and lower
panels). Apparently there was some glycerol metabolism:
the change in glycerol content decreased from
3,462% + 1,430% at zero min to 2,208% + 768% at
70 rain of moderately heavy ergometer exercise.
Citrate- Mean resting plasma citrate varied from
1.7 + 0.2 to 2.2 + 0.3 mg/dL, within the normal range of
1.7- 3.0 mg/dL (fig. 10, upper panel; appendix 2). Citrate
was present in all drinks: 3.87 g/2 L in PI, 7.74 g/2 L in
P2 and P2G, and 15.44 g/2 L in HA (table 2). Plasma
citrate increased by 0.5 pg/mL (P2G) to 1.7 pg/mL (HA),
and remained essentially constant with 0P! and 00 at zero
min (fig. 10, lower panel). In spite of the fact that drink
P1 was consumed during exercise with all treatments
except 00, citrate concentration in the four rest citrated
drinks converged at about 0.75 mg/dL at rest, with a
pronounced decrease in citrate with HA as consumption
changed from 15.44 g/2 L at rest to 3.87 g/2 L during
exercise. Reducing citrate consumption by 50% from rest
to exercise did not appreciably alter the change in citrate
content in the PIP1, P2PI, and P2GP1 treatments (fig. 10,
lower panel).
Urine Data
Excretion rate and electrolyte-osmotic concentration-
Urine excretion rate (V) at rest varied from
1.2 ± 0.3 mL/min (0Pl) to 3.2 ± 1.2 mL/min (P2GP1),
with a mean level (N = 6) of 2.3 + 0.3 mL/min (fig. 1 I,
solid line). Normal resting '_ is 1.0 mL/min. Excretion
rate during exercise varied from 0.8 ± 0.3 mL/min (0P 1
and 00) to 3.2 + 0.8 mL/min (HAP1), with a mean rate
(N = 6) of 1.8 + 0.4 mL/min (fig. 1I, dashed line) which
was not sig.nifi candy lower than the rest mean rate.
Exercise V was depressed similarly with P2PI, 0P1, and
00, but not with P2GP1 or HAP! with their higher
osmotic concentrations.
In general, urine sodium, potassium, and osmotic concen-
trations were lower with PIPI and P2P1, and higher with
HAPI, 0P1, and 00 treatments (table 6). The former
reflected the lower drink osmolality, while the latter
resulted from the greater ionic content of HAPI (in spite
of its lower osmolality); the urine response to dehydration
was similar to that following high salt consumption. The
somewhat elevated urine potassium concentration during
exercise over that at rest resulted from increased muscle
activity.
Sodium excretion- Mean (+SE) sodium excretion for the
six treatments was 168 + 19 laEq/min (p < 0.05) during
exercise (-15 to +10 min) (fig. 12, upper panel). The
large increase in UNa • "v"during rest and exercise with
HAP1wasduetoits high sodium concentration
(164 mEq/L).
Potassium excretion- There was no significant differ-
ence between mean UK" V at rest (58 + 8 I.tEq/min) and
during exercise of 75 + 20 taEq/min (fig. 12, lower panel).
The large increase in potassium excretion with HAPI dur-
ing exercise probably accompanied the fluid shift from
muscle cells to the interstitial and vascular spaces.
Osmotic clearance- There was no significant difference
between mean UOsm • _'/POsm at rest (3.0 +
0.2 mL/min) and during exercise (2.4 4- 0.4 mL/min)
(fig. 13, upper panel). The somewhat increased osmotic
clearance with HAP1 during exercise reflected the
increased concomitant excretion of sodium and
potassium.
Free water clearance- There was no significant
difference between mean free water clearance (CH20)
at rest (--0.74 _+0.23 mL/min) and during exercise
(--0.60 4- 0.24 mL/min) (fig. ! 3, lower panel). Treatments
with higher ionic content (HAP1) and dehydration (0PI
and 00) have the least CH2 O, suggesting greater water
retention.
Physiological Data
Heart rate- Mean heart rate varied from 71 + 6 to
87 4- 8 beats/min during the rest phase to 149 + 9 to
160 + 8 beats/min at 70 min of exercise (fig. 14, upper
panel). The increase in heart rate during exercise was
lowest (61 + 10 beats/min) with P1P1, and greatest
(74 + 10 beats/min) with HAP1 (fig. 14, lower panel).
Dehydration (00) did not result in the characteristic
elevated heart rate at rest or during exercise.
Rectal and mean skin temperatures- Mean (+SE) rectal
temperature (Tre) was stable with each treatment at rest; it
varied from 36.6 + 0.2°C with P2GP1 to 37.2 4. 0.1°C
with 0PI (fig. 15, upper panel). The range and variability
of Tre decreased by time zero. Equilibrium levels of Tre
at min 70 of exercise varied from 37.98 4. 0.10°C with
P1P1 to 38.29 4- 0.17°C with 0PI. Mean change in Tre
during exercise (fig. 15, lower panel) did not exhibit the
expected response where the 0PI and 00 changes in Tre
should have been the greatest. In fact, P2GP1 showed the
greatest increase (1.41 4- 0.13°C); followed by P2PI
( i. 34 + 0. ! 7°C), 00 ( i .33 +__0.14°C), HAP 1 (1.31 5:
0.14°C), 0P1 (1.25 4. 0.15°C), and P1PI (!.14 4. 0.08°C).
Thus it appears that glycerol ingestion tends to elevate Tre
whereas PI tends to attenuate the increase in Tre.
Absolute average mean skin temperatures (Tsk)(fig. 16,
upper panel) and the change in Tsk (fig. 16, lower panel)
were not significantly different between the six treat-
ments. Treatment 00 Tsk was nearest zero, while treat-
ment 0P1 tended to have the greater decrease (fig. 16,
lower panel). Lower Tsk suggests greater sweating and
evaporative heat loss.
Forearm and thigh sweat rates- Mean (4-SE) rest (time
zero) forearm sweat rate varied from 0.02 4- 0.02 mg/
min • cm 2 (0P1) to 0.16 4- 0.09 mg/min • cm 2 with P2GP1
(fig. 17, upper panel). Sweat rate was unchanged for the
first 10 min of exercise, when all rates began to rise to
reach 0.22 + 0.09 mg/min • cm 2 (00) to 0.49 + 0.11 mg/
min • cm 2 (0P1). Change in forearm sweat rate responded
similarly where 00 increased least (as expected) by
0.17 + 0.07 mg/min • cm2; and 0P1 increased most by
0.47 4- 0.10 mg/min, cm 2 (fig. 17, lower panel), sug-
gesting enhanced sweating when dehydration at rest
precedes drinking during exercise.
Thigh sweat rate at rest (time zero) was slightly higher
than forearm sweat rate (fig. 18, upper panel): it varied
from 0.05 + 0.02 mg/min - cm 2 (0P1) to 0.20 4- 0.03 mg/
min • cm 2 (P2GP1). Rates began to increase after 5 min of
exercise to reach 0.46 4- 0.05 mg/min • cm 2 (HA) to
0.060 4-0.07 mg/min - cm 2 (P2GPI), Change in thigh
sweat rate followed a similar pattern; HAP1 increased
least by 0.34 + 0.04 mg/min - cm 2, and 0P1 increased
most by 0.46 4- 0.08 mg/min • cm 2, similar to the forearm
sweating response. However, the change in 00 thigh rate
was also increased similar to that of the 0P1 rate, unlike
the change in forearm sweating where 00 had the most
attenuated rate.
Body water balance and sweat rate- Mean (+SE) body
water balance for the six treatments was 42 + 76 mL at
rest, and -650 + 81 mL (p < 0.01) during exercise
(fig. 19). Treatments PIP1 and P2P1 resulted in greater
positive balance and HAP1 had greater negative balance
at rest, indicating increased sweating, whereas P2PI had
the greatest negative balance and P2GP1 and HAPI the
lesser negative balances during exercise, indicating
reduced sweating (table 7). Treatments 0P1 and 00 had
virtually similar unchanged rest balances and negative
exercise balances, indicating that the latter were not
affected by consuming Pi (fig. 19).
Temple and thigh skin blood velocity- Mean (4.SE)
temple skin blood velocity (from an inactive area of the
body) was constant at rest, and varied from 0.35 + 0.05 to
0.62 4. 0.07 Hz- l02 among the subjects (fig. 20, upper
panel). All temple velocities increased after 5 rain of
exercise and, after about 55 rain, reached equilibrium
between 0.77 + 0.14 and 0.98 4. 0.15 Hz - 102 . Treatment
HAP1 had the lowest (0.26 + 0.11 Hz - 102) and 0P1 the
highest (0.50 4-0.13 Hz • 10 2) increase in velocity at
70 min of exercise (fig. 20, lower panel). Because about
25% of body heat loss comes from the head, reduced
templeskinbloodvelocityindicatesreducedheatrans-
portin thisregion.
Mean(_+SE)thighskinbloodvelocityfromanactivearea
duringexercisewasconstanta restandvariedfrom
0.264- 0.2 to 0.50 +_0.1 ! Hz • 10 2 (fig. 21, upper panel).
Unlike temple skin response, thigh skin velocity with
three treatments increased within 5 min of the start of
exercise and all treatment velocities increased to reach,
again after about 55 min of exercise, equilibrium levels
between 0.61 _+0. i 1 and 0.93 4- 0.42 Hz • 102. Treatment
P2GP! had the lowest (0.22 4- 0.16 Hz • 10 2) and 0Pl the
highest (0.64 4- 0.39 Hz • 102) increase in thigh skin
velocity at 70 rain of exercise (fig. 21, lower panel); in
fact, 0P1 blood velocity was elevated appreciably
throughout the exercise period.
Salient Responses from Each Treatment
P1P1
!. Significant increase in plasma volume at rest
2. Showed the only positive exercise urinary free water
clearance
3. Lowest change in exercise heart rate
4. Lowest change in exercise rectal temperature
P2P1
I. No effect of double strength [P1] on rest or exercise
plasma volume
2. Low exercise urinary volume
3. Highest positive water balance at rest
4. Greatest negative exercise water balance
HAP1
1. Significant increase in plasma volume at rest
2. Highest level of exercise plasma volume
3. Highest level of rest and exercise plasma sodium,
potassium, and osmotic content
4. Lowest plasma glucose concentration and content at
rest
5. High exercise plasma glucose content in spite of no
glucose intake
6. High exercise urinary volume
7. Highest rest and exercise urinary sodium excretion
8. Highest exercise urinary potassium and osmotic
excretion
9. Lower rest and exercise urinary free water clearance
I0. Greatest change (increase) in exercise heart rate
11. Least change in exercise thigh sweat rate
12. Showed the only negative water balance at rest
13. Least change in exercise temple skin blood flow
.
3.
4.
5.
6.
rate
7.
rate
8.
P2GPI
1. No effect of glycerol on rest or exercise plasma
volume
2. Higher urinary volume at rest
3. Greatest change (increase) in exercise rectal
temperature
4. Least change in exercise thigh skin blood flow
0P1
I. Compared with no drinking, P1 increased plasma
volume
Highest exercise plasma glucose content
Low rest and exercise urinary volume
Lower rest and exercise urinary free water clearance
Greatest change (increase) in exercise heart rate
Greatest change (increase) in exercise forearm sweat
Greatest change (increase) in exercise thigh sweat
Greatest change (increase) in exercise temple skin
blood flow
9.
00
I.
2.
3.
rate
Greatest change in exercise thigh skin blood flow
Low rest and exercise urinary volume
Lower rest and exercise urinary free water clearance
Least change (increase) in exercise forearm sweat
Conclusion
HyperAde (164 mEq/L Na+), with the lowest
osmolality of the four fluid formulations, maintained
plasma volume at rest and during exercise, whereas the
other formulations with low Na + and higher osmolality
(365 to 1,382 mOsm/kg) did not. However,
Performance 1 increased plasma volume at rest. Thus,
drink composition appears to be more important than
drink osmolality for increasing plasma volume at rest and
formaintainingit duringmoderatelyheavysubmaximal
exercise.
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Table 2. Drink composition per 2000 mL (package label data)
P1 b p2 c P2G d HA e
Sodium chloride (gm)
Sodium Citrate (gm)
Dextrose (gm)
Aspartame (gin)
Glycerol (gin)
Shaklee Performance a (gin)
Total
Total volume (mL)
Ionic concentration: (mEq/L, % weight/volume)
Na +
K+
CI-
Mg ++
Ca++
p++++
Total
- - - 9.00
3.87 7.74 7.74 t5.44
41.12 82.24 82.24 -
- - - 0.72
- - 100.87 -
222.28 444.56 444.56 -
222.28 444.56 444.56 25.16
2,000 2,000 2,000 2,000
19.61/0.04 39.22/0.09 39.22/0.09 157/0.36
5.01/0.02 10.02/0.04 10.02/0.04 -
4.98/0.02 9.96/0.04 9.96/0.04 76/0.27
0.40/0.01 0.80/0.01 0.80/0.01 -
1.96/0.02 3.92/0.03 3.92/0.03 -
0.51/0.01 1.02/0.02 1.02/0.02 -
32.47/0.11 69.94/0.22 69.94/0.22 233/0.63
Carbohydrate (% weight/volume)
Glucose
Fructose
Maltodextrin
Total
1.85 3.70 3.70
2.43 4.85 4.85
5.44 10.88 10.88
9.72 19.43 19.43
w
Measured drink solute concentrations
Na + (mEq/L)
K + (mEq/L)
Osmolality (mOsm/kgH20)
Glycerol (mg/dL)
Glucose (mg/dL)
Citrate (mg/dL)
55.2 97.1 112.7
5.3 10.3 10.7
365 791 1382
2.0 4.0 2916
2049 3579 3543
416 753 731
163.7
<0.1
253
1.0
<0.5
854
aShaklee U.S., Inc., San Francisco, CA 94111.
b Shaklee Performance.
CDouble-strength Shaklee Performance.
dDouble-strength Shaklee Performance plus 80 mL glycerol.
eHyperAde -NaCI/Na citrate (0.036% Na +)
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Table3. Individualdrinkvolume(10mL/kgbodyweight)fortherestandexercise
phases
Drink
Subject
PIP1 P2PI P2GP! HAPI 0PI 0
CAL 1,342 1,342 1,318 1,346 656 0
DUW !,978 2,018 2,000 1,984 977 0
GUF 1,112 1,092 1,106 1,102 561 0
PAU 1,800 1,785 1,794 1,812 892 0
PED 1,264 1,274 1,266 1,268 627 0
REA 1,708 1,696 1,722 1,720 866 0
m
X 1,534 1,535 1,534 1,539 796 0
±SD 342 353 353 348 164 0
±SE 140 144 144 142 67 0
Table 4. Individual subject rest and submaximal exercise data a
Subject "QO2 rest, Ixmd, a "_O2 exercise, a "QO2 exercise, a VO 2 exercise,a
L/min kg-m/min L/min % peak mL/min - kg
CAL 0.34 700 1.80 68 27
DUW 0.44 900 2.43 83 25
GUF 0.31 700 1.70 65 30
PAU 0.44 900 2.46 69 28
PED 0.38 1000 2.19 62 34
REA 0.40 700 1.90 72 22
m
X 0.39 817 2.08 70 28
±SD 0.05 133 0.33 7 4
±SE 0.02 54 0.13 3 2
a _ of six treatments.
"QO 2 = oxygen uptake.
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Table5. Meanenvironmentalp rametersforthesixtreatments
Variable
i
PIPI P2P! P2GPI HAP1 0PI 00 Mean
Dry bulb temperature (°C)
Relative humidity (%)
Wind speed (ft/min)
R_t ph_e
X 22.2 21.9 21.4 21.8 22.1 21.4 21.8
±SD 0.9 1.1 0.5 0.8 0.6 0.2 0.3
±SE 0.4 0.4 0.2 0.3 0.3 0.1 0.1
I
X 50 48 45 48 52 51 49
±SD 5 5 I 4 6 2 3
±SE 2 2 1 2 3 1 !
X 23 16 25 25 29 22 23
±SD 8 8 8 7 12 5 4
±SE 3 3 3 3 5 2 2
Barometric pressure (mmHg)
Dry bulb temperature (°C)
Relative humidity (%)
Wind speed (ft/min)
Barometric pressure (mmHg)
m
X 764.3 764.3 763. I 764.1 762.5 763.5 763.6
±SD 1.0 2.0 1.8 0.7 0.9 2.2 0.7
+SE 0.4 0.8 0.8 0.3 0.4 0.9 0.3
Exercise phase
22.2 21.8 21.0 21.6 22.2 21.9 21.8
+SD 0.8 1.2 0.3 0.5 0.6 0.3 0.4
±SE 0.3 0.5 0.1 0.2 0.2 0.1 0.2
X 49 49 46 51 52 51 50
+SD 5 2 3 I 5 3 2
±SE 2 1 1 1 2 1 !
X 53 60 49 54 52 52 53
+SD 6 15 5 1 6 6 4
+_SE 3 6 2 ! 3 3 2
764.0 764.1 763.2 764.0 762.2 763.7 763.5
+SD 1.2 1.7 1.9 0.8 1.0 2.4 0.7
+SE 0.5 0.7 0.8 0.3 0.4 1.0 0.3
Rest phase data are averages of-65- and -35-min values; exercise phase data are averages of 3_0- and
60-rain values.
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Table6. Mean(+SE)urine lectrolyteconcentrationsfortherest(-105to-15min)and
exercise(-! 5to+I0min)phasesforthesixtreatments
Variable PIPI P2PI P2GP1 HAPI 0PI 00
UrineNa+(I.tEq/L) 63.3
(17.4)
UrineK+(l.tEq/L) 18.2
(4.1)
Osmolality(mOsm/kgH20) 328
(56)
UrineNa+(I.tEq/L) 47.6
(8.6)
UrineK+(laEq/L) 27.4
(3.8)
Osmolality(mOsm/kgH20)280
(33)
Rest phase
65.8 81.1 i00.4 113.1 111.2
(17.5) (22.8) (18.6) (17.7) (21.7)
17.8 29.0 39.8 51.7 66.8
(4.5) (8.0) (8.2) (14.1) (22.1)
368 443 498 752 712
(62) (121) (79) (146) (135)
Exercise phase
72.9 55.1 80.6 102.3 126.5
(22.4) (7.8) (19.9) (12.2) (18.9)
53.6 27.1 58.5 85.9 90.2
(24.5) (2. I) (6.2) (13.4) (! 9.2)
451 397 442 781 843
(124) (87) (89) (116) (105)
Table 7. Mean (+SE) water balance, respiratory water loss, insensible water loss, and sweat rate
for the rest (-105 to -I 5 min) and exercise (-15 to 70 rain) phases for the six treatments
Variable P 1P I P2P 1 P2GP ! HAP 1 0P I 00
Water balance, g/m 2 • hr 47
(19)
Respiratory water loss, g/m 2. hr 12
(1)
Insensible water loss, g/m 2 • hr 18
Sweat rate, g/m 2 • hr 77
(19)
Water balance, g/m 2 • hr -197
(42)
Respiratory water loss, g/m 2. hr 49
(2)
Insensible water loss, g/m 2 - hr 18
Sweat rate, g/m 2 . hr 130
(4O)
Rest phase
93 I -78 6 -23
(52) (23) (47) (39) (65)
12 12 12 10 I0
(1) (1) (I) (l) O)
18 18 18 18 18
123 31 -48 34 -5
(52) (22) (47) (39) (65)
Exercise phase
-315 -125 -151 -237 -221
(73) (34) (31 ) (73) (62)
50 52 49 50 49
(3) (2) (1) (4) (3)
18 18 18 18 18
247 55 84 169 154
(72) (34) (30) (7 I) (59)
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-- Rest phase
(sitting)
-qF -- Exercise phase -
(sitting)
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Figure 1. Experimental protocol. UR = urine, BL = blood sample, EB = Evans blue injection, BW = body weight,
_'0 2 = oxygen uptake, and D = drinking (1/14 of total volume).
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Figure 2. Comparison of manual and automatic (Coulter counter) measurement for hemoglobin and hematocrit at rest and
during exercise ('X +- SE).
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Figure 8. Mean (+_SE)plasma glucose concentration at rest and during exercise for the six treatments.
20
2°°1-
180_
1601- "_
,_ 140 t//
Ioo 
_ 6o
E
40
20 ,_
0 _i i I I __"// ' I I I I
200 -
180
160
.J
_ 140
E
" 120
>, 100
80
_ 6o
"_ 40
20
0
-120 -100
A P1/P1
o P2/P1
• P2G/P1 _ _ -r-
- • HA/P1
_ [] O/P1 T
-80 -60 -40 -20 0 20 40 60 +10
Time (rain)
Figure 9. Mean (_+SE)plasma glycerol concentration at rest and during exercise for the six treatments.
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Figure 10. Mean (+_SE)plasma citrate concentration at rest and during exercise for the six treatments.
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Figure 16. Mean (_+SE)mean skin temperature at rest and during exercise for the six treatments.
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Figure 17. Mean (+SE) forearm sweat rate at rest and during exercise for the six treatments.
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Figure 18. Mean (_+SE)thigh sweat rate at rest and during exercise for the six treatments.
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Figure 19. Mean (_+SE) water balance at rest and during exercise for the six treatments.
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Figure 20. Mean (+_SE)forehead skin blood velocity at rest and during exercise for the six treatments.
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Figure 21. Mean (_+SE)legskin blood velocity at rest and during exercise for the six treatments.
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Appendix I. Mean metabolic data at rest and during exercise for the six treatments
VESTPD
RE
PIP! P2P1 P2GP! HAPI 0PI 00 Mean
Rest phase(--45min)
X 11.42 11.33 10.92 11.81 10.05 10.17 10.95
±SD 2.73 1.60 1.56 3.10 2.85 2.76 0.71
±SE 1.11 0.65 0.64 i.26 1.16 !.13 0.29
X 0.97 0.96 0.94 0.95 0.91 0.97 0.95
+SD 0.06 0.02 0.07 0.05 0.06 0.09 0.02
+SE 0.02 0.01 0.03 0.02 0.02 0.04 0.01
VO 2 (1Lmin) X" 0.40 0,39 0.40 0.40 0.36 0.35 0.38
+SD 0.08 0.05 0.03 0.08 0.07 0.08 0.02
+SE 0.03 0.02 0.01 0.03 0.03 0.03 0.01
"v'O2 (mL/min • kg) X 5.6 5.4 5.8 5.8 4.6 4.6 5.3
+_SD 1.0 0.6 I. 1 0.5 0.5 0.3 0.6
+SE 0.4 0.2 0.4 0.2 0.2 0.1 0.2
VESTPD
RE
_'O 2 (L/min)
VO 2 (mL/min • kg)
VE STPD
Exercise phase(35min)
48.45 48.74 50.64 49.54 51.81 48.60 49.63
±SD 10.89 12.04 10.76 10.13 16.96 I3.85 1.34
±SE 4.45 4.92 4.39 4.13 6.92 5.65 0.55
X 0.97 0.96 0.98 0.94 0.96 0.96 0.96
±SD 0.02 0.02 0.07 0.07 0.03 0.02 0.01
+SE 0.01 0.01 0.03 0.03 0.01 0.01 0.01
X 2.01 2.09 2.08 2.12 2.03 2.02 2.06
±SD 0.32 0.35 0.28 0.38 0.38 0.38 0.04
+SE 0.13 0.14 0.il 0.15 0.15 0.15 0.02
28.2 29.1 29.6 29.9 27.4 26.8 28.5
±SD 4.4 6.1 3.7 4.2 3.9 3.8 1.2
___SE 1.8 2.5 1.5 1.7 1.6 1.5 0.5
Exercise phase(65min)
48.19 49.41 48.59 47.70 50.37 48.38 48.94
±SD 11.51 10.79 9.53 8.43 13.78 t0.51 0.93
±SE 4.55 4.40 3.89 3.44 5.63 4.29 0.38
0.94 0195 0.96 0.94 0.94 0.94 0.95
±SD 0.05 0102 0.04 0.03 0.04 0.04 0.01
±SE 0.02 0.01 0.02 0.01 0.02 0.02 0.01
RE
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Appendix1.Concluded
902 (L/min)
VO2(mL/min•kg)
2.14 2.12 2.05 2.11 2.12 2.10 2.11
+SD 0.38 0.32 0.29 0.30 0.38 0.35 0.03
+SE 0.16 0.13 0.12 0.12 0.15 0.14 0.01
X 29.9 29.4 29.1 29.6 28.6 27.9 29.1
±SD 4.7 5.0 3.5 4.1 3.4 4.0 0.7
±SE 1.9 2.0 1.4 1.7 1.4 1.6 0.3
Appendix 2. Mean plasma citrate concentration at rest and during exercise for
the six treatments
Rest phase Exercise phase
Time (min) -105 0 10 30 70
Treatment
P1P1
P2P1
P2GP 1
HAP1
0P1
00
X 1.7 2.3 2.4 1.9 2.4
±SD 0.4 0.8 0.7 0.7 0.6
±SE 0.2 0.3 0.3 0.3 0.2
w
X 1.8 2.5 2.7 2.4 2.6
±SD 0.5 0.7 0.8 0.8 0.7
±SE 0.2 0.3 0.3 0.3 0.3
X !.8 2.2 2.4 2.5 2.6
±SD 0.8 0.6 0.7 0.7 0.6
±SE 0.3 0.3 0.3 0.3 0.3
m
X 1.8 3.4 2.9 2.7 2.5
±SD 0.5 0.6 0.6 0.5 0.6
±SE 0.2 0.3 0.3 0.2 0.2
2.2 1.8 2.0 1.8 2.3
±SD 0.6 0.7 0.5 0.7 0.7
±SE 0.3 0.3 0.2 0.3 0.3
1.9 1.7 i.9 1.9 2.1
±SD 0.7 0.5 0.9 0.6 0.5
±SE 0.3 0.2 0.4 0.2 0.2
Normal range = 1.7 - 3.0 mg/dL.
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Appendix3. Meanhemoglobinconcentrationandhematocrita restandduringexercisefor
thesixtreatments
36
Restphase Exercisephase
Time(min) -105
Treatment
Hemoglobin
-30 -25
m
X 16.3 16.4 16.3
P 1P 1 +SD 0.5 1.0 0.6
+SE 0.2 0.4 0.2
X 16.6 16.4 16.4
P2P1 +SD 0.4 0.7 0.6
+SE 0.2 0.3 0.2
X 16.6 16.6 16.5
P2GPI +SD 0.4 0.5 0.4
+SE 0.2 0.2 0.2
X 16.6 16.1 16.0
HAP1 ___SD 0.5 0.4 0.5
+SE 0.2 0.1 0.2
X 17.4 16.8 16.9
0PI +SD 1.1 1.1 I. 1
+SE 0,4 0.4 0.4
X 16.6 16.6 16.4
00 +SD 0.3 0.7 0.5
+_SE 0.1 0.3 0.2
Normal range = 13.6 - i7.2 gldL.
Time (min) -105
Treatment
P1P1
P2PI
P2GP I
HAP1
0PI
00
-3O
Hematocrit
-25
m
X 45.3 45.9 45.6
+SD 1.5 1.8 1.7
+SE 0.6 0.7 0.7
X 46.7 46.2 46.0
+SD 2.3 1.9 1.9
+SE 0.9 0.8 0.8
46.8 46.6 46.2
+SD 1.7 1.8 1.4
+SE 0.7 0.7 0.6
46.4 45.3 44.9
+SD 1.2 1.0 1.4
+SE 0.5 0,4 0.6
X 48.4 47.0 47.2
+SD 2.1 2.2 1.9
+SE 0.8 0.9 0.8
X 46.6 46.1 46.4
±SD 0.8 1.4 1.5
+SE 0.3 0.6 0,6
Normal range = 39% - 49%.
0 10 30 70
16.4 17.0 17.0 16.5
0.8 0.7 0.6 0.6
0.3 0.3 0.3 0.2
16.6 17.0 17.1 17.0
0.6 0.6 0.4 0.7
0.3 0.2 0.2 0.3
16.4 17.0 17.0 16.8
0.6 0.8 0.6 0.5
0.3 0.3 0.2 0.2
16.1 16.6 16.4 16.4
0.8 0.4 0.5 0.6
0.3 0.2 0.2 0.3
17.3 18.0 17.7 17.4
1.0 1.2 1.4 1.4
0.4 0.5 0.6 0.6
16.8 17.5 17.3 17.2
0.9 0.5 0.8 0.9
0.4 0.2 0.3 0.4
0 10 30 70
45.8 47.4 46.8 46.0
2.5 2.2 1.7 2.1
1.0 0.9 0.7 0.9
46.5 47.8 47.5 46.5
1.9 1.7 1.2 1.0
0.8 0.7 0.5 0.4
46.7 48.1 47.3 47.0
1.9 1.9 2.0 1.9
0.8 0.8 0.8 0,8
45.6 46.1 45.4 45.2
2.6 1.9 2.0 2.2
1. ! 0.8 0.8 0.9
48.4 50.1 49.1 48.1
2.0 2.4 2.9 2.8
0.8 !.0 1.2 i.1
47.1 49.0 47.9 47.3
1.8 1.6 1.7 2.1
0.7 0.6 0.7 0.9
Illl
Appendix 4. Mean red blood cell and white blood cell (leukocyte) concentrations at rest
and during exercise for the six treatments
Rest phase Exercise phase
Red cells
- 105 -30 -25 0 10 30 70Time (min)
Treatment
PIPI _-kSD
_+.SE
P2PI _+_SD
_-kSE
P2GP1 _-kSD
+SE
X
HAP1 +SD
+SE
X
0P1 +SD
+SE
X
00 +SD
+SE
5.33 5.26 5.23 5.24 5.48 5.43 5.38
0.30 0.25 0.24 0.24 0.26 0.20 0.28
0.12 0.10 0.10 0.10 0.11 0.08 0.|1
5.36 5.30 5.27 5.33 5.50 5.54 5.46
0.31 0.20 0.25 0.22 0.20 0.20 0.20
0.13 0.08 0.10 0.09 0.08 0.08 0.08
5.34 5.32 5.28 5.33 5.53 5.49 5.47
0.35 0.30 0.28 0.33 0.35 0.33 0.32
0.14 0.12 0.11 0.14 0.14 0.14 0.13
5.32 5.18 5.14 5.23 5.32 5.30 5.27
0.27 0.18 0.22 0.31 0.31 0.26 0.27
0.11 0.07 0.09 0.13 0.13 0.10 0.11
5.62 5.48 5.43 5.55 5.78 5.75 5.66
0.27 0.30 0.23 0.23 0.30 0.38 0.38
0.11 0.12 0.09 0.09 0.12 0.16 0.16
5.39 5.34 5.36 5.42 5.71 5.64 5.55
0.15 0.17 0.19 0.15 0.21 0.19 0.28
0.06 0.07 0.08 0.06 0.09 0.08 0.11
Normal range = 4.3-5.9 x 106/mm 3 .
Time (min) - 105
Treatment
-30
White cells
-25 0 10 30 70
X 5.2 4.9 4.9 5.5 7.2 7.4 7. I
P1P1 +_.SD 1.9 !.8 1.7 1.3 2.0 2.4 2.7
_t_SE 0.8 0.8 0.7 0.5 0.8 ! .0 1.1
X 4.6 4.3 4.7 5.2 6.4 7.0 7. I
P2P1 +-SD 1.4 !.2 0.7 0.6 1.8 1.9 2.0
+-SE 0.6 0.5 0.3 0.3 0.7 0.8 0.8
X 4.7 4.5 4.5 5.2 6.8 7.4 7.1
P2GP 1 +.+-SD 0.9 1.0 1.1 1.4 1.8 2.2 2.1
+SE 0.4 0.4 0.4 0.6 0.7 0.9 0.9
4.9 4.6 4.7 5.5 6.2 6.6 6.6
HAP1 :£SD 1.0 0.9 0.8 1.8 1.3 1.5 1.5
+SE 0.4 0.4 0.3 0.8 0.5 0.6 0.6
X 5.6 5.2 5.1 5.5 7.6 8.0 7.9
0PI +SD 1.0 0.6 0.7 0.6 1.0 1.2 1.4
+SE 0.4 0.3 0.3 0.3 0.4 0.5 0.6
X 4.6 4.7 4.6 5.0 7.0 7.0 7.5
00 +SD 1.1 1.3 1.3 1.4 2.1 2,4 3.4
+SE 0.5 0.5 0.5 0.6 0.8 1.0 1.4
Normal range = 3.2-9.8 x 103/mm 3.
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Appendix5. Meanplatelet( hrombocyte)concentrationatrestandduringexerciseforthesix
treatments
Restphase Exercisephase
- 105 -30 -25 0 10 30 70Time(min)
Treatment
P1PI
210 210 204 206 226 250 260
±SD 33 44 38 34 43 49 60
±SE 13 18 16 14 18 20 24
P2Pi
210 212 206 217 240 259 246
±SD 50 58 53 64 59 54 88
±SE 20 24 22 26 24 22 36
P2GP!
211 216 212 216 244 248 270
±SD 46 47 50 47 47 57 60
±SE 19 19 20 19 19 23 25
HAP1
218 210 209 204 226 224 240
±SD 47 42 40 23 50 60 51
±SE 19 17 16 10 20 25 21
0PI
215 225 220 220 239 248 279
±SD 32 33 48 53 47 54 40
±SE 13 14 19 22 19 22 16
00
202 206 198 206 221 232 240
±SD 43 41 43 41 33 35 38
±SE 18 17 18 17 13 14 16
Normalrange= 150- 450x 103/mm3.
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Appendix6. Individualrestinghematocritandplasmandbloodvolumesforthesixtreatments
Subject Date CorrectedabsorbanceDyeinjected,Hct, Plasmavolume,Bloodvolume,
(treatment) pre-dye/post-dye mL % mL mL
CAL 8II9/93 0.005
(00) 0.037 2.6123 46.3 3240 5598
8/26/93 0.011
(PIP1) 0.051 2.5329 45.4 2536 4321
9/2/93 0.008
(0P1) 0.050 2.7194 45.5 2562 4372
9/16/93 0.010
(P2GP1) 0.052 2.5604 48.6 2471 4430
9/23/93 0.020
(HAP1) 0.050 2.6036 46.0 3539 6087
9/27/93 0.024
(P2PI) 0.052 2.4783 46.8 3609 6286
w
X 2.5845 46.4 2993 5182
+SD 0.0823 1.2 530 914
+SE 0.0336 0.5 216 373
DUW 8/18/93 0.005
(0P1) 0.031 2.6860 48.6 4112 7373
8/25/93 0.009
(00) 0.038 2.5103 46.4 3467 6000
9/1/93 0.008
(HAP1) 0.034 2.5974 46.7 3880 6747
9/8/93 0.008
(P1P1) 0.034 2.5701 46.8 3911 6812
9/15/93 0.016
(P2P 1) 0.040 2.5502 45.7 4178 7153
9/22/93 0.014
(P2GP1) 0.037 2.5804 47.0 4575 7994
X 2.5824 46.9 4020 7013
• SD 0.0589 1.0 368 671
±SE 0.0240 0.4 150 274
GUF 8/19/93 0.004
(00) 0.044 2.5716 49.2 2551 4620
8/26/93 0.013
(PIPI) 0.062 2.6174 48.5 2139 3829
9/2/93 0.015
(0P1) 0.055 2.6029 45.8 2527 4333
9/9/93 0.015
(P2P1) 0.065 2.6039 48.9 2060 3712
9/16/93 0.031
(P2GP1) 0.062 2.4945 46.4 3164 5476
9/23/93 0.023
(HAPI) 0.065 2.5431 45.8 2454 4208
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Appendix6.Continued
m
X
+SD
+SE
2.5732 47.4 2482
O.0475 !.6 392
0.0194 0.6 160
4363
639
261
PAU 8/i 8/93
(0P 1)
8125/93
(oo)
9/1/93
(HAP ! )
9/8/93
(P1Pl)
9/15/93
(P2P1)
9122/93
(P2GP1)
0.005
0.041
0.010
0.046
0,010
0.044
0.012
0.047
0.020
0.050
0.014
0.054
2.6221 50.2 2899
2.5099 44.7 2792
2.5532 43.6 2916
2.6284 44.5 2971
2.5706 43.8 3369
2.5799 45.0 2614
5338
4707
4834
4993
5602
4427
u
X
+_SD
+SE
2.5744 45.3 2927
0.0443 2,5 251
0.0181 1.0 102
4984
428
175
PED 8/17/93
(p2Pl)
8/24/93
(0P ! )
8/3 !/93
(P2GPI)
9/7/93
(oo)
9/I 4/93
(HAP 1)
9/21/93
(PIPI)
0.003
0.034
0.012
0.044
0.013
0.045
0,015
0.055
0.026
0.052
0.019
0.058
2.5038 46.7 3215
2.5538 47.5 3167
2.6018 45.1 3158
2.5890 46.4 2561
2.5791 43.5 3900
2.6069 43.7 2709
i
X 2.5724 45.5 3118
5591
5578
5355
4432
6456
4498
5318
_+SD
+SE
0.0385 1.6 470
0.0157 0.7 192
761
311
REA 8/I 6/93
(PIPI)
8/24/93
(HAP I )
8/30/93
(P2P1)
9113/93
(P2GP ! )
9/20/93
(0P 1)
9/27/93
(oo)
0,004
0.041
0.009
0.040
0.009
0.040
0.015
0.044
0,012
0.050
0.022
0.046
2.5370 44,9 2729
2.5617 45,6 3279
2.5069 44.3 3140
2.5124 45.4 3406
2.5330 45,7 2702
2.4971 45.6 4243
4615
5605
5262
5805
4626
7252
4O
Appendix6.Concluded
_+SD
+SE
2.5247
0.0237
0.0097
45.2
0.6
0.2
3250
565
231
5528
977
399
From -35 to -25 min.
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